Nymi is set to welcome Chris Sullivan as its new Chief Executive Officer.Chris joins Nymi as the business sees strong market demand and a rapidly growing customer base in pharmaceutical manufacturing. This is a reflection of the company's current state: ready for the future after a strong year of growth.Sullivan's appointment caps off a significant year in Nymi's growth as a business. Working with the top 100 Pharmaceutical companies globally, use cases for Nymi have created more secure logins for manufacturing execution systems, and made e-signatures more efficient for smart factories and labs.Nymi is a venture-funded private company with investment from top venture and strategic investors including Ignition Partners, Relay Ventures, GII Tech Ventures, Mastercard, Konica Minolta, and Export Development Canada. They see Chris Sullivan's appointment as a key addition in the next phase of the company.Vijay Parmar, Executive Chairman of Nymi and Partner at GII Tech Ventures said: “Nymi has established itself as the leader in authentication within Pharmaceutical manufacturing. Working with global pharmaceuticals, we're helping companies be secure, compliant and productive all at the same time. Chris brings a wealth of security and operational expertise that will help Nymi step into its next phase of growth. With his leadership, Nymi is ready to start to expand beyond pharma into industrial and general enterprise use.”Chris Sullivan is a business-minded executive who has spent his career finding the practical applications of security technologies. His experience working with Fortune 100, 500 and 1000 companies at the CISO and CIO level brings a new level of expertise to Nymi. Outside of Nymi, Chris will continue his work to advance industry best practices across the public and private sectors with organizations like the Advanced Cyber Security Center, the Natural Technology Security Coalition, the CISO Coalition, and ISACA.